ADC Therapeutics SA (ADCT)

ADC Therapeutics Revenue

ADC Therapeutics had revenue of $19.25M in the quarter ending June 30, 2026, with 2.17% growth. This brings the company's total for the last twelve months to $79.58M, up 3.03% year-over-year. In the year 2025, ADC Therapeutics had annual revenue of $81.36M with 14.85% growth. That makes ADC Therapeutics the 24,429th largest company in the world by revenue and 3,444th in the United States.

• Revenue (ttm): $79.58M
• Revenue Growth: +3.03%
• P/S Ratio: 2.60
• Revenue / Employee: $412,352
• Employees: 193
• Market Cap: 206.82M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States 73.55M 90.4%
• Europe, The Middle East and Africa 7.81M 9.6%

Fiscal year ended Dec 31, 2025 See the full ADC Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	81.36M	10.52M	14.85%
Dec 31, 2024	70.84M	1.28M	1.84%
Dec 31, 2023	69.56M	-140.35M	-66.86%
Dec 31, 2022	209.91M	175.99M	518.89%
Dec 31, 2021	33.92M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error